Science Experimental Heart Drug Pelacarsen Fails Clinical Trial Despite Cutting Lp(a) Levels by 78% November 7, 2026 An experimental drug once hailed as a breakthrough in preventing heart attacks and strokes has failed a crucial clinical trial, despite successfully lowering a key blood protein linked to cardiovascular…
Health Novo Nordisk Shares Plunge as Heart Drug Trial Fails to Meet Key Goal August 1, 2026 Novo Nordisk faced a sharp selloff on Friday after the Danish pharmaceutical giant announced that its experimental heart drug ziltivekimab failed to achieve its primary goal in a late-stage clinical…